October Pharma S.A.E (EGX: OCPH)

October Pharma S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	47.68	45.3	6.92	16.72	1.86	17.21
Cash & Short-Term Investments	47.68	45.3	6.92	16.72	1.86	17.21
Cash Growth	78.91%	554.89%	-58.64%	798.79%	-89.19%	16.36%
Accounts Receivable	235.98	209.3	144.45	97.04	84.73	73.63
Other Receivables	-	0.24	0.27	0.41	0.34	0.22
Receivables	767.87	579.83	364.81	118.84	214.67	175.65
Inventory	277.11	167.62	252.86	167.84	140.73	87.89
Prepaid Expenses	-	4.52	1.59	0.89	0.64	0.76
Other Current Assets	37.95	33.24	29.45	26.56	27.68	24.65
Total Current Assets	1,131	830.51	655.63	330.86	385.59	306.16
Property, Plant & Equipment	255.21	216.84	196.27	115.76	107.8	112.02
Other Intangible Assets	83.44	90.74	98.18	105.4	112.76	120.33
Other Long-Term Assets	-	-	-	1.03	-	-
Total Assets	1,469	1,138	950.08	553.06	606.15	538.52
Accounts Payable	161.46	82.27	92.51	35.37	26.22	33.97
Accrued Expenses	-	16.95	22.99	23.76	26	26.99
Short-Term Debt	424.39	216.99	203.34	15.25	165.64	162.74
Current Portion of Long-Term Debt	50.96	38.15	41.36	18.16	24.38	23.7
Current Portion of Leases	-	0.26	0.42	0.37	-	-
Current Income Taxes Payable	39.96	61.55	41.29	37.37	22.7	10.53
Other Current Liabilities	40.14	40.99	22.66	21.91	15.48	16.64
Total Current Liabilities	716.9	457.17	424.56	152.19	280.43	274.56
Long-Term Debt	79.81	68.57	77.42	39.69	58.3	71
Long-Term Leases	-	-	0.26	0.68	-	-
Long-Term Deferred Tax Liabilities	14.27	12.78	11.78	10.33	2.85	0.6
Total Liabilities	820.64	548.55	524.55	213.6	352.29	358.06
Common Stock	120	120	120	60	60	60
Retained Earnings	528.62	469.54	305.52	279.46	193.86	120.46
Shareholders' Equity	648.62	589.54	425.52	339.46	253.86	180.46
Total Liabilities & Equity	1,469	1,138	950.08	553.06	606.15	538.52
Total Debt	555.15	323.98	322.79	74.15	248.32	257.44
Net Cash (Debt)	-507.47	-278.68	-315.87	-57.43	-246.46	-240.23
Net Cash Per Share	-24.56	-23.22	-26.32	-4.79	-20.54	-20.02
Filing Date Shares Outstanding	12	12	12	12	12	12
Total Common Shares Outstanding	12	12	12	12	12	12
Working Capital	413.71	373.34	231.07	178.67	105.16	31.6
Book Value Per Share	54.05	49.13	35.46	28.29	21.16	15.04
Tangible Book Value	565.18	498.79	327.34	234.05	141.1	60.13
Tangible Book Value Per Share	47.10	41.57	27.28	19.50	11.76	5.01
Land	-	0.42	0.42	0.42	0.42	0.42
Buildings	-	36.19	36.12	35.78	35.72	34.64
Machinery	-	145.86	148.8	141.84	136.56	114.51
Construction In Progress	-	129.44	100.41	19	6.57	26.37

Source: S&P Capital IQ. Standard template. Financial Sources.